Author: Nicholas Caito

Domains within RbpA serve specific functional roles that regulate the expression of distinct mycobacterial gene subsets.

Prusa J., Jensen D., Santiago-Collazo G., Pope S.S., Garner A.L., Miller J.J., Ruiz Manzano A., Galburt E.A., & Stallings C.L. (2018). “Domains within RbpA serve specific functional roles that regulate the expression of distinct mycobacterial gene subsets.” J Bacteriol. 2018 Apr 23. pii: JB.00690-17. doi: 10.1128/JB.00690-17. (Abstract)

MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A.

Rocha A.G., Franco A., Krezel A.M., Rumsey J.M., Alberti J.M., Knight W.C., Biris N., Zacharioudakis E., Janetka J.W., Baloh R.H., Kitsis R.N., Mochly-Rosen D., Townsend R.R., Gavathiotis E., & Dorn G.W. 2nd (2018). “MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A.” Science. 2018 Apr 20;360(6386):336-341. doi: 10.1126/science.aao1785. (Abstract)

Dr. Frazier to Be Honored for Innovation and Entrepreneurship

Dr. William Frazier will receive the Chancellor’s Award for Innovation and Entrepreneurship. Chancellor Mark S. Wrighton will present Dr. Frazier and two others with awards during a ceremony October 5th, 2018 at The Ritz-Carlton Hotel in Clayton.

Dr. Frazier

“Professors Achilefu, Elgin and Frazier represent the very best of Washington University and join the distinguished company of previous winners who have worked creatively and diligently to discover and disseminate new knowledge that brings great benefit to society,” Wrighton said.

You can read more about this at The Source.

Targeting Hepatocyte Growth Factor with Protease Inhibitors in Lung Cancer

April 9th, 2018 – Jim Janetka, PhD, Associate Professor of Biochemistry and Molecular Biophysics, and Co-Founder of ProteXase Therapeutics, Inc., along with Lidija Klampfer, PhD, Co-Founder and Chief Scientific Officer of ProteXase Therapeutics, Inc., received a one-year SBIR grant award from the National Cancer Institute for their research entitled “Targeting Hepatocyte Growth Factor with Protease Inhibitors in Lung Cancer”.